327 filings
Page 9 of 17
8-K
kupsxi of5liq6geyf
7 May 15
ZIOPHARM Reports First-Quarter 2015 Financial Results and Recent Activities
12:00am
8-K
uxd5zvs
7 May 15
Departure of Directors or Certain Officers
12:00am
8-K
nlfae d8zn
27 Apr 15
ZIOPHARM Announces Initiation of Phase 1b/2 Study of Ad-RTS-hIL-12
12:00am
8-K
rvw9x 0z4
2 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
og9j9
1 Apr 15
Other Events
12:00am
8-K
b55qpadro7r
30 Mar 15
ZIOPHARM-Intrexon Synthetic Immuno-Oncology Programs Strengthened through Collaboration with Merck Serono
12:00am
8-K
xs9hkrh x47e
26 Feb 15
ZIOPHARM Reports Fourth-Quarter and Full-Year 2014 Financial Results and Recent Activities
12:00am
8-K
hnxy7q
12 Feb 15
ZIOPHARM Oncology Announces Exercise of Option to Purchase Additional Shares
12:00am
8-K
ajkjcc mf
4 Feb 15
Entry into a Material Definitive Agreement
12:00am
8-K
9pp10yq47xhwb3vx28
4 Feb 15
ZIOPHARM Oncology Announces Pricing of Public Offering of Common Stock
12:00am
8-K
natla7174
2 Feb 15
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
12:00am
8-K/A
ync37erw
28 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
igalr
14 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
o7b9s00 4m
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
3ppc78d 7eozmx
3 Dec 14
ZIOPHARM and Intrexon Present Clinical and Preclinical Data from Immuno-Oncology Programs at AACR Tumor Immunology and Immunotherapy Meeting
12:00am
8-K
cef04n
30 Oct 14
ZIOPHARM Reports Third-Quarter 2014 Financial Results
12:00am
8-K
o1aiyor
16 Sep 14
Unregistered Sales of Equity Securities
12:00am
8-K
4m4p 82qkp
7 Aug 14
Results of Operations and Financial Condition
12:00am
8-K
vmzas apt
31 Jul 14
ZIOPHARM Oncology and Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin
12:00am
8-K
js94oj8kzwcixhukf8
19 Jun 14
Departure of Directors or Certain Officers
12:00am